|
AMASSplus
- Released on 25 Mar 2021
Description:
The AMASSplus application is an extension of AMASS Version 1.1 that was released on 12 January 2021. AMASSplus has an additional report (page 38-40) on selected notifiable bacterial diseases. For implementation of AMASSplus at your hospitals in Thailand, please contact Preeyarach Klaytong (preeyarach@tropmedres.ac) and Viriya Hantrakun (viriya@tropmedres.ac).
AMASS version 1.1
- Released on 12 Jan 2021
Description:
This is a version with bugs fixed. AMASS 1.1 fixes a typo in the R codes of the AMASS 1.0 that caused inaccurate estimations of the proportion of non-susceptible isolates of E. coli and K. pneumoniae for ampicillin (page 9-10 and page 18-21 in the AMR surveillance report).
Version Beta 12102019
- Released on 12 Oct 2019
Description:
This is a beta version with new sections added, typos corrected and bug fixed from Version_Beta_26022019. In this version, there are 6 completed sections. The sections are [1] Data overview; [2] Isolated-based surveillance report without stratification by infection origin; [3] Isolated-based surveillance report with stratification by infection origin; [4] Sample-based surveillance report without stratification by infection origin; [5] Sample-based surveillance report with stratification by infection origin; and [6] Mortality in AMR and antimicrobial-susceptible infections.
Version Beta 26022019
- Released on 16 Feb 2019
Description:
This is the first released version of AMASS that contained 4 main sections. The sections are [1] General demographic data; [2] Isolated-based surveillance report without stratification by infection origin; [3] Isolated-based surveillance report with stratification by infection origin; and [5] Mortality in AMR and antimicrobial-susceptible infections. Please note that in this version, Section [4] on Sample-based surveillance report was under development (incomplete).
|